Orient Technologies (NSE: ORIENTTECH) Q3 FY26 results: Why short-term margin pain may be the price of securing long-cycle government and services revenue
Read More 5 minute read Healthcare Industry News Precision Cell Systems consolidates cell analysis tech through dual acquisitions to serve 700+ research customers Discover how Precision Cell Systems is consolidating cell analysis tech through key acquisitions to serve 700+ research customers globally. bySoujanya RaviSeptember 17, 2025